Cargando…

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the accumulation of immature myeloid progenitor cells in the bone marrow, compromising of normal blood cell production and ultimately resulting in bone marrow failure. With a 20% overall survival rate at 5 years and 50% in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andresen, Vibeke, Gjertsen, Bjørn T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712546/ https://www.ncbi.nlm.nih.gov/pubmed/29238707 http://dx.doi.org/10.3389/fmed.2017.00211

Ejemplares similares

Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML)
por: Omsland, Maria, et al.
Publicado: (2016)

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling
por: Mercatelli, Daniele, et al.
Publicado: (2020)

Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia
por: Andresen, Vibeke, et al.
Publicado: (2016)

Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
por: Kuenzi, Brent M., et al.
Publicado: (2019)

Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia
por: Sletta, Kristine Yttersian, et al.
Publicado: (2021)

Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?
por: Wojcicki, Anna V., et al.
Publicado: (2020)

Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia
por: Leitch, Calum, et al.
Publicado: (2016)

PB1785: DISCOVERY OF APPROVED LOW-TOXICITY AGENTS DISRUPTING ACUTE MYELOID LEUKEMIA STEM AND PROGENITOR CELLS
por: Meilstrup, J., et al.
Publicado: (2022)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Acute Myeloid Leukemia: Is That All There Is?
por: Saif, Aneeqa, et al.
Publicado: (2018)

Early response evaluation by single cell signaling profiling in acute myeloid leukemia
por: Tislevoll, Benedicte Sjo, et al.
Publicado: (2023)

Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
por: Devaux, Christian A., et al.
Publicado: (2021)

Clinical proteomics of myeloid leukemia
por: Hjelle, Sigrun M, et al.
Publicado: (2010)

A scoring system based on fusion genes to predict treatment outcomes of the non-acute promyelocytic leukemia pediatric acute myeloid leukemia
por: Weng, Wenwen, et al.
Publicado: (2023)

Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
por: Fredly, Hanne, et al.
Publicado: (2013)

Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
por: Piccolomo, Antonio, et al.
Publicado: (2020)

Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia
por: Natarajan, Aparna, et al.
Publicado: (2019)

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
por: Fredly, Hanne, et al.
Publicado: (2013)

Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia
por: Tislevoll, Benedicte Sjo, et al.
Publicado: (2023)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia?
por: Valli, Debora, et al.
Publicado: (2020)

Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

Bazex Syndrome in Acute Myeloid Leukemia
por: Oka, Satoko, et al.
Publicado: (2023)

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
por: Regan, Kelly, et al.
Publicado: (2016)

Acute Myeloid Leukemia: A “Head to Toe” Examination
por: Calleja, Robert, et al.
Publicado: (2020)

Neutropenic Enterocolitis in a Patient With Acute Myeloid Leukemia
por: Becker, Erica C, et al.
Publicado: (2022)

Intensive chemotherapy for acute myeloid leukemia differentially affects circulating T(C)1, T(H)1, T(H)17 and T(REG )cells
por: Ersvaer, Elisabeth, et al.
Publicado: (2010)

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2020)

A Case of Therapy-related Acute Myeloid Leukemia Following Treatment with 5-Fluorouracil
por: Pinczés, László, et al.
Publicado: (2018)

Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine
por: Omsland, Maria, et al.
Publicado: (2018)

Acute Myeloid Leukemia Complicated by Hyperleukocytosis and Leukostasis in the Emergency Department
por: Ngo, Ryan T, et al.
Publicado: (2021)

Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia
por: Øyan, Anne Margrete, et al.
Publicado: (2009)

Identification of Trypanosoma cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing
por: Reigada, Chantal, et al.
Publicado: (2019)

Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy
por: Grønningsæter, Ida Sofie, et al.
Publicado: (2019)

A Rare Case of Therapy-Related B-cell Acute Lymphoblastic Leukemia Arising From Acute Myeloid Leukemia
por: Ravikumar, Vishvaas, et al.
Publicado: (2023)

The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer
por: Tychhon, Boranai, et al.
Publicado: (2023)

Analysis of Medical Error Contributing to Missed Acute Myeloid Leukemia Diagnosis
por: Angel, Chelsea, et al.
Publicado: (2019)

Acute Myeloid Leukemia With Systemic Lupus Erythematosus: Rare Association or Coincidence
por: Tahri, Samah, et al.
Publicado: (2021)

Paraplegia as a Rare Clinical Presentation of Relapsed Acute Myeloid Leukemia
por: Osman, Haitham, et al.
Publicado: (2023)

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells
por: Reikvam, Håkon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cdsv1bn458rraaidp6po8ld7rs